AGP Executive Report
Last update: 10 hours agoObesity drug deal: Novo Nordisk agreed to pay up to US$2.6 billion to China’s Hengrui for HRS-1596, a phase 1-ready once-weekly oral GLP-1/GIP dual agonist aimed at obesity and type 2 diabetes—Novo gets exclusive rights outside mainland China, Hong Kong, Macao and Taiwan, with a US$300m upfront plus milestone payments and royalties. Food safety alert: Macau’s IAM ordered a recall after a black truffle sauce (“Familie”, “Black Truffle Sauce Natural Truffle 5%”) was found to contain excessive total arsenic; residents are urged to stop eating the affected batch. Holiday healthcare access: Macao Union Medical Center will close most outpatient services on Oct 1–2, while emergency, inpatient and hemodialysis services continue; assisted reproduction will run only for pre-scheduled appointments. Heat relief for the public: Hong Kong’s Home Affairs Department opened 19 temporary heat shelters on Oct 1, with cooling upgrades, drinking water access, and overnight bedding when very hot weather warnings are in force. Local health services milestone: The Hospital Authority held a flag-raising ceremony for the PRC’s 77th anniversary, highlighting staff pride and ongoing health system work. Injury update: A rider suffered multiple abrasions after a taxi failed to give way at a Pac On junction; the rider was taken to Conde de São Januário Hospital Centre.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
